The global microneedle drug delivery systems market is expected to grow at a CAGR of 16.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for microneedles in various applications such as drug delivery, vaccine delivery, and others. The hollow microneedle technology segment is expected to dominate the global microneedle drug delivery systems market during the forecast period due to its advantages such as high precision and accuracy in delivering drugs into cells and tissues. The global microneedle drug delivery systems market by type is segmented into hollow microneedles technology, solid microneedles technology, dissolving micro needles technology; by application it is segmented into drug delivery, vaccine delivery; by region it is segmented into North America (US, Canada), Latin America (Mexico), Europe (Germany, France), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
- Increasing prevalence of chronic diseases such as diabetes and obesity is driving the growth of the global Microneedle Drug Delivery Systems market.
- Increasing adoption of minimally invasive procedures for drug delivery is also driving the growth of the global Microneedle Drug Delivery Systems market.
- The increasing number of research and development activities in this field are also contributing to the growth of this market.
- The high cost associated with these devices is a major restraint for this market.
Industry Growth Insights published a new data on “Microneedle Drug Delivery Systems Market”. The research report is titled “Microneedle Drug Delivery Systems Market research by Types (Hollow Microneedle Technology, Solid Microneedle Technology, Dissolving Microneedles Technology), By Applications (Drug Delivery, Vaccine Delivery, Other, ), By Players/Companies 3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG, ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Microneedle Drug Delivery Systems Market Research Report
By Type
Hollow Microneedle Technology, Solid Microneedle Technology, Dissolving Microneedles Technology
By Application
Drug Delivery, Vaccine Delivery, Other,
By Companies
3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Microneedle Drug Delivery Systems Market Report Segments:
The global Microneedle Drug Delivery Systems market is segmented on the basis of:
Types
Hollow Microneedle Technology, Solid Microneedle Technology, Dissolving Microneedles Technology
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Delivery, Vaccine Delivery, Other,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M
- Zosano Pharma
- Becton-Dickinson(BD)Technologies
- Nanopass Technologies
- Corium
- Valeritas
- Nitto
- Microdermics
- TheraJect
- Vaxxas
- Lohmann Therapie-Systeme AG
Highlights of The Microneedle Drug Delivery Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hollow Microneedle Technology
- Solid Microneedle Technology
- Dissolving Microneedles Technology
- By Application:
- Drug Delivery
- Vaccine Delivery
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microneedle Drug Delivery Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microneedle drug delivery systems are devices that use microneedles to inject drugs directly into the body. Microneedles are tiny needles made from a variety of materials, including metal, plastic, and glass. They are inserted through the skin using a needle holder and then injected with an insulin or other medication.nnThe benefits of microneedle drug delivery systems include:nn- Reduced pain and discomfort associated with traditional injections - Microneedles can be administered quickly and without drawing blood - Microneedles can be used to deliver multiple doses of medication at once - Reduced risk of infection due to less exposure to bacteria
Some of the major players in the microneedle drug delivery systems market are 3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG.
The microneedle drug delivery systems market is expected to register a CAGR of 16.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Microneedle Drug Delivery Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Microneedle Drug Delivery Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Microneedle Drug Delivery Systems Market - Supply Chain
4.5. Global Microneedle Drug Delivery Systems Market Forecast
4.5.1. Microneedle Drug Delivery Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Microneedle Drug Delivery Systems Market Size (000 Units) and Y-o-Y Growth
4.5.3. Microneedle Drug Delivery Systems Market Absolute $ Opportunity
5. Global Microneedle Drug Delivery Systems Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Microneedle Drug Delivery Systems Market Size and Volume Forecast by Type
5.3.1. Hollow Microneedle Technology
5.3.2. Solid Microneedle Technology
5.3.3. Dissolving Microneedles Technology
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Microneedle Drug Delivery Systems Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Microneedle Drug Delivery Systems Market Size and Volume Forecast by Application
6.3.1. Drug Delivery
6.3.2. Vaccine Delivery
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Microneedle Drug Delivery Systems Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Microneedle Drug Delivery Systems Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Microneedle Drug Delivery Systems Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Microneedle Drug Delivery Systems Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Microneedle Drug Delivery Systems Demand Share Forecast, 2019-2026
9. North America Microneedle Drug Delivery Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Microneedle Drug Delivery Systems Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Microneedle Drug Delivery Systems Market Size and Volume Forecast by Application
9.4.1. Drug Delivery
9.4.2. Vaccine Delivery
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Microneedle Drug Delivery Systems Market Size and Volume Forecast by Type
9.7.1. Hollow Microneedle Technology
9.7.2. Solid Microneedle Technology
9.7.3. Dissolving Microneedles Technology
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Microneedle Drug Delivery Systems Demand Share Forecast, 2019-2026
10. Latin America Microneedle Drug Delivery Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Microneedle Drug Delivery Systems Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Microneedle Drug Delivery Systems Market Size and Volume Forecast by Application
10.4.1. Drug Delivery
10.4.2. Vaccine Delivery
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Microneedle Drug Delivery Systems Market Size and Volume Forecast by Type
10.7.1. Hollow Microneedle Technology
10.7.2. Solid Microneedle Technology
10.7.3. Dissolving Microneedles Technology
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Microneedle Drug Delivery Systems Demand Share Forecast, 2019-2026
11. Europe Microneedle Drug Delivery Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Microneedle Drug Delivery Systems Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Microneedle Drug Delivery Systems Market Size and Volume Forecast by Application
11.4.1. Drug Delivery
11.4.2. Vaccine Delivery
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Microneedle Drug Delivery Systems Market Size and Volume Forecast by Type
11.7.1. Hollow Microneedle Technology
11.7.2. Solid Microneedle Technology
11.7.3. Dissolving Microneedles Technology
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Microneedle Drug Delivery Systems Demand Share, 2019-2026
12. Asia Pacific Microneedle Drug Delivery Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Microneedle Drug Delivery Systems Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Microneedle Drug Delivery Systems Market Size and Volume Forecast by Application
12.4.1. Drug Delivery
12.4.2. Vaccine Delivery
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Microneedle Drug Delivery Systems Market Size and Volume Forecast by Type
12.7.1. Hollow Microneedle Technology
12.7.2. Solid Microneedle Technology
12.7.3. Dissolving Microneedles Technology
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Microneedle Drug Delivery Systems Demand Share, 2019-2026
13. Middle East & Africa Microneedle Drug Delivery Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Microneedle Drug Delivery Systems Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Microneedle Drug Delivery Systems Market Size and Volume Forecast by Application
13.4.1. Drug Delivery
13.4.2. Vaccine Delivery
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Microneedle Drug Delivery Systems Market Size and Volume Forecast by Type
13.7.1. Hollow Microneedle Technology
13.7.2. Solid Microneedle Technology
13.7.3. Dissolving Microneedles Technology
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Microneedle Drug Delivery Systems Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Microneedle Drug Delivery Systems Market: Market Share Analysis
14.2. Microneedle Drug Delivery Systems Distributors and Customers
14.3. Microneedle Drug Delivery Systems Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3M
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zosano Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Becton-Dickinson(BD)Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nanopass Technologies
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Corium
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Valeritas
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Nitto
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Microdermics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. TheraJect
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Vaxxas
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Lohmann Therapie-Systeme AG
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook